https://medicaldialogues.in/pulmonology/news/dual-lamalaba-or-triple-therapy-may-raise-cv-risk-among-copd-patients-100530
0
0
Dual LAMA/LABA or triple therapy may raise CV risk among COPD patients - Medical Dialogues
+ 70 more
10/17/22 at 2:00pm
Organization
Medical Dialogues
Author
Dr. Kamal Kant Kohli
Details
30 words
Summarize
Health Respiratory Conditions LAMA LABA China COPD LABA The European Respiratory Journal
CHINA: According to a research reported in The European Respiratory Journal, dual LAMA/LABA or...
Create an account or login to join the discussion